Trends & Forecasts

Donald Trump has vowed to lower drug prices, but what about his policies in other areas?

Martin Van Trieste tells the emotional story behind the creation of Rx-360

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

What better way to engage with patients than partnering with Marvel Custom Solutions?

Elliott Berger offers his top 10 marketing tips for contract manufacturing organizations.

A campaign to counter criticism and a first foray into biosimilars… What’s new in business?

What does the legalization of medical cannabis mean for conventional pharmaceuticals?

PhRMA and the ABPI showcase the industry’s good side and the science behind the logo.

Marathon Pharmaceuticals’ pricing of Emflaza for Duchenne muscular dystrophy causes controversy

It’s not easy finding your way “from a garage to a palace...”